{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:07:56Z","timestamp":1793959676994,"version":"4.8.0"},"reference-count":53,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inactivation of the von Hippel-Lindau tumor suppressor, pVHL, is associated with both hereditary and sporadic renal cysts and renal cell carcinoma, which are commonly thought to arise from the renal proximal tubule. pVHL regulates the protein stability of hypoxia-inducible factor (HIF)-\u03b1 subunits and loss of pVHL function leads to HIF stabilization. The role of HIF in the development of VHL-associated renal lesions remains to be determined. To investigate the functional consequences of pVHL inactivation and the role of HIF signaling in renal epithelial cells, we used the phosphoenolpyruvate carboxykinase (PEPCK) promoter to generate transgenic mice in which Cre-recombinase is expressed in the renal proximal tubule and in hepatocytes. We found that conditional inactivation of VHL in PEPCK-Cre mutants resulted in renal cyst development that was associated with increased erythropoietin levels and polycythemia. Increased expression of the HIF target gene erythropoietin was limited to the liver, whereas expression of carbonic anhydrase 9 and multidrug resistance gene 1 was up-regulated in the renal cortex of mutant mice. Inactivation of the HIF-\u03b1 binding partner, arylhydrocarbon receptor nuclear translocator (Arnt), but not Hif-1\u03b1, suppressed the development of renal cysts. Here, we present the first mouse model of VHL-associated renal disease that will provide a basis for further genetic studies to define the molecular events that are required for the progression of VHL-associated renal cysts to clear cell renal cell carcinoma. (Cancer Res 2006; 66(5): 2576-83)<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-3241","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T19:23:23Z","timestamp":1141241003000},"page":"2576-2583","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":326,"title":["Renal Cyst Development in Mice with Conditional Inactivation of the von Hippel-Lindau Tumor Suppressor"],"prefix":"10.1158","volume":"66","author":[{"given":"Erinn B.","family":"Rankin","sequence":"first","affiliation":[{"name":"1Department of Medicine and Cell and Molecular Biology Graduate Group, Program in Cell Growth and Cancer and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Tomaszewski","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker H.","family":"Haase","sequence":"additional","affiliation":[{"name":"1Department of Medicine and Cell and Molecular Biology Graduate Group, Program in Cell Growth and Cancer and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"key":"2022061622115888600_B1","doi-asserted-by":"crossref","unstructured":"Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science\u20081993; 260: 1317\u201320.","DOI":"10.1126\/science.8493574"},{"key":"2022061622115888600_B2","doi-asserted-by":"crossref","unstructured":"Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet\u20082003; 361: 2059\u201367.","DOI":"10.1016\/S0140-6736(03)13643-4"},{"key":"2022061622115888600_B3","doi-asserted-by":"crossref","unstructured":"Gnarra JR, Tory K, Weng Y, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet\u20081994; 7: 85\u201390.","DOI":"10.1038\/ng0594-85"},{"key":"2022061622115888600_B4","doi-asserted-by":"crossref","unstructured":"Iliopoulos O, Kibel A, Gray S, Kaelin WG, Jr. Tumour suppression by the human von Hippel-Lindau gene product. Nat Med\u20081995; 1: 822\u20136.","DOI":"10.1038\/nm0895-822"},{"key":"2022061622115888600_B5","doi-asserted-by":"crossref","unstructured":"Gnarra JR, Zhou S, Merrill MJ, et al. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci U S A\u20081996; 93: 10589\u201394.","DOI":"10.1073\/pnas.93.20.10589"},{"key":"2022061622115888600_B6","doi-asserted-by":"crossref","unstructured":"Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis [see comments]. Nature\u20081999; 399: 271\u20135.","DOI":"10.1038\/20459"},{"key":"2022061622115888600_B7","doi-asserted-by":"crossref","unstructured":"Iliopoulos O, Levy AP, Jiang C, Kaelin WG, Jr., Goldberg MA. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A\u20081996; 93: 10595\u20139.","DOI":"10.1073\/pnas.93.20.10595"},{"key":"2022061622115888600_B8","doi-asserted-by":"crossref","unstructured":"Ivan M, Kondo K, Yang H, et al. HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science\u20082001; 292: 464\u20138.","DOI":"10.1126\/science.1059817"},{"key":"2022061622115888600_B9","doi-asserted-by":"crossref","unstructured":"Iwai K, Yamanaka K, Kamura T, et al. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci U S A\u20081999; 96: 12436\u201341.","DOI":"10.1073\/pnas.96.22.12436"},{"key":"2022061622115888600_B10","doi-asserted-by":"crossref","unstructured":"Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science\u20082001; 292: 468\u201372.","DOI":"10.1126\/science.1059796"},{"key":"2022061622115888600_B11","doi-asserted-by":"crossref","unstructured":"Maynard MA, Qi H, Chung J, et al. Multiple splice variants of the human HIF-3\u03b1 locus are targets of the VHL E3 ubiquitin ligase complex. J Biol Chem\u20082003; 21: 21.","DOI":"10.1074\/jbc.M208681200"},{"key":"2022061622115888600_B12","doi-asserted-by":"crossref","unstructured":"Kewley RJ, Whitelaw ML, Chapman-Smith A. The mammalian basic helix-loop-helix\/PAS family of transcriptional regulators. Int J Biochem Cell Biol\u20082004; 36: 189\u2013204.","DOI":"10.1016\/S1357-2725(03)00211-5"},{"key":"2022061622115888600_B13","doi-asserted-by":"crossref","unstructured":"Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol\u20082001; 13: 167\u201371.","DOI":"10.1016\/S0955-0674(00)00194-0"},{"key":"2022061622115888600_B14","doi-asserted-by":"crossref","unstructured":"Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J\u20082002; 16: 1151\u201362.","DOI":"10.1096\/fj.01-0944rev"},{"key":"2022061622115888600_B15","doi-asserted-by":"crossref","unstructured":"Freeburg PB, Abrahamson DR. Divergent expression patterns for hypoxia-inducible factor-1\u03b2 and aryl hydrocarbon receptor nuclear transporter-2 in developing kidney. J Am Soc Nephrol\u20082004; 15: 2569\u201378.","DOI":"10.1097\/01.ASN.0000141464.02967.29"},{"key":"2022061622115888600_B16","doi-asserted-by":"crossref","unstructured":"Rosenberger C, Mandriota S, Jurgensen JS, et al. Expression of hypoxia-inducible factor-1\u03b1 and -2\u03b1 in hypoxic and ischemic rat kidneys. J Am Soc Nephrol\u20082002; 13: 1721\u201332.","DOI":"10.1097\/01.ASN.0000017223.49823.2A"},{"key":"2022061622115888600_B17","doi-asserted-by":"crossref","unstructured":"Wiesener MS, Jurgensen JS, Rosenberger C, et al. Widespread hypoxia-inducible expression of HIF-2\u03b1 in distinct cell populations of different organs. FASEB J\u20082003; 17: 271\u20133.","DOI":"10.1096\/fj.02-0445fje"},{"key":"2022061622115888600_B18","doi-asserted-by":"crossref","unstructured":"Mandriota SJ, Turner KJ, Davies DR, et al. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell\u20082002; 1: 459\u201368.","DOI":"10.1016\/S1535-6108(02)00071-5"},{"key":"2022061622115888600_B19","doi-asserted-by":"crossref","unstructured":"Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH. Up-regulation of hypoxia-inducible factors HIF-1\u03b1 and HIF-2\u03b1 under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene\u20082000; 19: 5435\u201343.","DOI":"10.1038\/sj.onc.1203938"},{"key":"2022061622115888600_B20","doi-asserted-by":"crossref","unstructured":"Raval RR, Lau KW, Tran MG, et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol\u20082005; 25: 5675\u201386.","DOI":"10.1128\/MCB.25.13.5675-5686.2005"},{"key":"2022061622115888600_B21","doi-asserted-by":"crossref","unstructured":"Zimmer M, Doucette D, Siddiqui N, Iliopoulos O. Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL\u2212\/\u2212 tumors. Mol Cancer Res\u20082004; 2: 89\u201395.","DOI":"10.1158\/1541-7786.89.2.2"},{"key":"2022061622115888600_B22","doi-asserted-by":"crossref","unstructured":"Kondo K, Klco JM, Nakamura E, Lechpammer M, Kaelin WG. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell\u20082002; 1: 237\u201346.","DOI":"10.1016\/S1535-6108(02)00043-0"},{"key":"2022061622115888600_B23","doi-asserted-by":"crossref","unstructured":"Kondo K, Kim WY, Lechpammer M, Kaelin WG, Jr. Inhibition of HIF2\u03b1 is sufficient to suppress pVHL-defective tumor growth. PLoS Biol\u20082003; 1: E83.","DOI":"10.1371\/journal.pbio.0000083"},{"key":"2022061622115888600_B24","unstructured":"Kragel PJ, Walther MM, Pestaner JP, Filling-Katz MR. Simple renal cysts, atypical renal cysts, and renal cell carcinoma in von Hippel-Lindau disease: a lectin and immunohistochemical study in six patients. Mod Pathol\u20081991; 4: 210\u20134."},{"key":"2022061622115888600_B25","doi-asserted-by":"crossref","unstructured":"Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med\u20081996; 335: 865\u201375.","DOI":"10.1056\/NEJM199609193351207"},{"key":"2022061622115888600_B26","doi-asserted-by":"crossref","unstructured":"Paraf F, Chauveau D, Chretien Y, Richard S, Grunfeld JP, Droz D. Renal lesions in von Hippel-Lindau disease: immunohistochemical expression of nephron differentiation molecules, adhesion molecules and apoptosis proteins. Histopathology\u20082000; 36: 457\u201365.","DOI":"10.1046\/j.1365-2559.2000.00857.x"},{"key":"2022061622115888600_B27","doi-asserted-by":"crossref","unstructured":"Haase VH, Glickman JN, Socolovsky M, Jaenisch R. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci U S A\u20082001; 98: 1583\u20138.","DOI":"10.1073\/pnas.98.4.1583"},{"key":"2022061622115888600_B28","unstructured":"Ryan HE, Poloni M, McNulty W, et al. Hypoxia-inducible factor-1\u03b1 is a positive factor in solid tumor growth. Cancer Res\u20082000; 60: 4010\u20135."},{"key":"2022061622115888600_B29","doi-asserted-by":"crossref","unstructured":"Walisser JA, Bunger MK, Glover E, Harstad EB, Bradfield CA. Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele. J Biol Chem\u20082004; 279: 16326\u201331.","DOI":"10.1074\/jbc.M400784200"},{"key":"2022061622115888600_B30","doi-asserted-by":"crossref","unstructured":"Doetschman T, Gregg RG, Maeda N, et al. Targeted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature\u20081987; 330: 576\u20138.","DOI":"10.1038\/330576a0"},{"key":"2022061622115888600_B31","doi-asserted-by":"crossref","unstructured":"Bronson SK, Plaehn EG, Kluckman KD, Hagaman JR, Maeda N, Smithies O. Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci U S A\u20081996; 93: 9067\u201372.","DOI":"10.1073\/pnas.93.17.9067"},{"key":"2022061622115888600_B32","doi-asserted-by":"crossref","unstructured":"Rankin EB, Higgins DF, Walisser JA, Johnson RS, Bradfield CA, Haase VH. Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Mol Cell Biol\u20082005; 25: 3163\u201372.","DOI":"10.1128\/MCB.25.8.3163-3172.2005"},{"key":"2022061622115888600_B33","doi-asserted-by":"crossref","unstructured":"Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res\u20081991; 19: 4293.","DOI":"10.1093\/nar\/19.15.4293"},{"key":"2022061622115888600_B34","doi-asserted-by":"crossref","unstructured":"MacGregor GR, Zambrowicz BP, Soriano P. Tissue non-specific alkaline phosphatase is expressed in both embryonic and extraembryonic lineages during mouse embryogenesis but is not required for migration of primordial germ cells. Development\u20081995; 121: 1487\u201396.","DOI":"10.1242\/dev.121.5.1487"},{"key":"2022061622115888600_B35","doi-asserted-by":"crossref","unstructured":"Hanson RW, Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem\u20081997; 66: 581\u2013611.","DOI":"10.1146\/annurev.biochem.66.1.581"},{"key":"2022061622115888600_B36","doi-asserted-by":"crossref","unstructured":"Beale EG, Clouthier DE, Hammer RE. Cell-specific expression of cytosolic phosphoenolpyruvate carboxykinase in transgenic mice. FASEB J\u20081992; 6: 3330\u20137.","DOI":"10.1096\/fasebj.6.15.1281456"},{"key":"2022061622115888600_B37","doi-asserted-by":"crossref","unstructured":"Patel YM, Yun JS, Liu J, McGrane MM, Hanson RW. An analysis of regulatory elements in the phosphoenolpyruvate carboxykinase (GTP) gene which are responsible for its tissue-specific expression and metabolic control in transgenic mice. J Biol Chem\u20081994; 269: 5619\u201328.","DOI":"10.1016\/S0021-9258(17)37506-3"},{"key":"2022061622115888600_B38","doi-asserted-by":"crossref","unstructured":"Schulte BA, Spicer SS. Histochemical evaluation of mouse and rat kidneys with lectin- horseradish peroxidase conjugates. Am J Anat\u20081983; 168: 345\u201362.","DOI":"10.1002\/aja.1001680308"},{"key":"2022061622115888600_B39","doi-asserted-by":"crossref","unstructured":"Sikri KL, Foster CL, Bloomfield FJ, Marshall RD. Localization by immunofluorescence and by light- and electron-microscopic immunoperoxidase techniques of Tamm-Horsfall glycoprotein in adult hamster kidney. Biochem J\u20081979; 181: 525\u201332.","DOI":"10.1042\/bj1810525"},{"key":"2022061622115888600_B40","doi-asserted-by":"crossref","unstructured":"Linehan WM, Zbar B. Focus on kidney cancer. Cancer Cell\u20082004; 6: 223\u20138.","DOI":"10.1016\/j.ccr.2004.09.006"},{"key":"2022061622115888600_B41","doi-asserted-by":"crossref","unstructured":"Kaelin WG, Jr. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer\u20082002; 2: 673\u201382.","DOI":"10.1038\/nrc885"},{"key":"2022061622115888600_B42","doi-asserted-by":"crossref","unstructured":"Grabmaier K, A de Weijert MC, Verhaegh GW, Schalken JA, Oosterwijk E. Strict regulation of CAIX(G250\/MN) by HIF-1\u03b1 in clear cell renal cell carcinoma. Oncogene\u20082004; 23: 5624\u201331.","DOI":"10.1038\/sj.onc.1207764"},{"key":"2022061622115888600_B43","unstructured":"Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res\u20082002; 62: 3387\u201394."},{"key":"2022061622115888600_B44","doi-asserted-by":"crossref","unstructured":"Semenza GL, Koury ST, Nejfelt MK, Gearhart JD, Antonarakis SE. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci U S A\u20081991; 88: 8725\u20139.","DOI":"10.1073\/pnas.88.19.8725"},{"key":"2022061622115888600_B45","doi-asserted-by":"crossref","unstructured":"Maxwell PH, Osmond MK, Pugh CW, et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int\u20081993; 44: 1149\u201362.","DOI":"10.1038\/ki.1993.362"},{"key":"2022061622115888600_B46","doi-asserted-by":"crossref","unstructured":"Wiesener MS, Seyfarth M, Warnecke C, et al. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma. Blood\u20082002; 99: 3562\u20135.","DOI":"10.1182\/blood.V99.10.3562"},{"key":"2022061622115888600_B47","doi-asserted-by":"crossref","unstructured":"Witzgall R, Brown D, Schwarz C, Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest\u20081994; 93: 2175\u201388.","DOI":"10.1172\/JCI117214"},{"key":"2022061622115888600_B48","doi-asserted-by":"crossref","unstructured":"Vannay A, Fekete A, Adori C, et al. Divergence of renal vascular endothelial growth factor mRNA expression and protein level in post-ischaemic rat kidneys. Exp Physiol\u20082004; 89: 435\u201344.","DOI":"10.1113\/expphysiol.2004.027516"},{"key":"2022061622115888600_B49","doi-asserted-by":"crossref","unstructured":"Pavlovich CP, Schmidt LS, Phillips JL. The genetic basis of renal cell carcinoma. Urol Clin North Am\u20082003; 30: 437\u201354, vii.","DOI":"10.1016\/S0094-0143(03)00023-5"},{"key":"2022061622115888600_B50","doi-asserted-by":"crossref","unstructured":"Walther MM, Lubensky IA, Venzon D, Zbar B, Linehan WM. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol\u20081995; 154: 2010\u20134; discussion 4\u20135.","DOI":"10.1097\/00005392-199512000-00007"},{"key":"2022061622115888600_B51","doi-asserted-by":"crossref","unstructured":"Solomon D, Schwartz A. Renal pathology in von Hippel-Lindau disease. Hum Pathol\u20081988; 19: 1072\u20139.","DOI":"10.1016\/S0046-8177(88)80089-3"},{"key":"2022061622115888600_B52","doi-asserted-by":"crossref","unstructured":"Lee YS, Vortmeyer AO, Lubensky IA, et al. Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma. Clin Cancer Res\u20082005; 11: 1059\u201364.","DOI":"10.1158\/1078-0432.1059.11.3"},{"key":"2022061622115888600_B53","doi-asserted-by":"crossref","unstructured":"Westenfelder C, Baranowski RL. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int\u20082000; 58: 647\u201357.","DOI":"10.1046\/j.1523-1755.2000.00211.x"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/5\/2576\/2559332\/2576.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/5\/2576\/2559332\/2576.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T16:45:36Z","timestamp":1683391536000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/5\/2576\/526856\/Renal-Cyst-Development-in-Mice-with-Conditional"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,3,1]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-3241","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}